Erin Reese
Internal Medicine · San Antonio, TXNPI 1366615643
Payments from drug & device makers
Across 169 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$441
- AbbVie$307
- Lilly USA, LLC$257
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$248
- Almatica Pharma LLC$238
- Johnson & Johnson$172
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,759100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 37 | $441 |
| AbbVie | 19 | $307 |
| Lilly USA, LLC | 14 | $257 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $248 |
| Almatica Pharma LLC | 13 | $238 |
| Johnson & Johnson | 10 | $172 |
| Esperion Therapeutics, Inc. | 9 | $127 |
| Abbott | 5 | $93 |
| Boehringer Ingelheim | 3 | $83 |
| GSK | 4 | $75 |
| Vivus LLC | 3 | $74 |
| Amarin Pharma, Inc. | 4 | $71 |
| Bausch Health US, LLC | 3 | $55 |
| Novo Nordisk | 3 | $49 |
| Millicent US Inc | 3 | $46 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Grifols USA, LLC | 2 | $41 |
| Novartis | 2 | $38 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Vertex | 1 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Merck | 2 | $34 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Neuronetics, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Vertiflex, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
How this compares
$2,759 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 152 | $180,590 |
| JardianceEmpagliflozin | 74 | $122,611 |
| XareltoRivaroxaban | 24 | $33,225 |
| OzempicSemaglutide | 30 | $30,091 |
| NexletolBempedoic Acid | 31 | $27,525 |
| EliquisApixaban | 19 | $22,822 |
| ZenpepLipase/Protease/Amylase | 12 | $20,581 |
| TrulicityDulaglutide | 12 | $19,409 |
| UbrelvyUbrogepant | 16 | $16,638 |
| NexlizetBempedoic Acid/Ezetimibe | 13 | $14,407 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 17 | $5,406 |
| OsphenaOspemifene | 14 | $4,900 |
| Estradiol | 35 | $4,205 |
| SynthroidLevothyroxine Sodium | 35 | $3,999 |
| Rosuvastatin Calcium | 208 | $2,990 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $257 | $199,999164 claims |
| Boehringer IngelheimJardiance | $83 | $122,61174 claims |
| Esperion Therapeutics, Inc.Nexletol, Nexlizet | $127 | $41,93244 claims |
| Johnson & JohnsonXarelto | $172 | $33,22524 claims |
| Novo NordiskOzempic | $49 | $30,09130 claims |
| PfizerEliquis | $441 | $22,82219 claims |
| AbbVieUbrelvy, Synthroid | $307 | $20,63751 claims |
| GSKArexvy, Shingrix | $75 | $8,37830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.